PT1877052E - Derivados de benzimidazole e sua utilização para modulação do complexo do receptor gabaa - Google Patents
Derivados de benzimidazole e sua utilização para modulação do complexo do receptor gabaa Download PDFInfo
- Publication number
- PT1877052E PT1877052E PT06725630T PT06725630T PT1877052E PT 1877052 E PT1877052 E PT 1877052E PT 06725630 T PT06725630 T PT 06725630T PT 06725630 T PT06725630 T PT 06725630T PT 1877052 E PT1877052 E PT 1877052E
- Authority
- PT
- Portugal
- Prior art keywords
- modulating
- receptor complex
- benzimidazole derivatives
- gabaa receptor
- gabaa
- Prior art date
Links
- 102000027484 GABAA receptors Human genes 0.000 title 1
- 108091008681 GABAA receptors Proteins 0.000 title 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67064705P | 2005-04-13 | 2005-04-13 | |
| DKPA200500530 | 2005-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1877052E true PT1877052E (pt) | 2009-08-25 |
Family
ID=36658703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT06725630T PT1877052E (pt) | 2005-04-13 | 2006-04-07 | Derivados de benzimidazole e sua utilização para modulação do complexo do receptor gabaa |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7851490B2 (pt) |
| EP (1) | EP1877052B1 (pt) |
| JP (1) | JP2008535891A (pt) |
| KR (1) | KR20070119691A (pt) |
| AU (1) | AU2006233894A1 (pt) |
| CA (1) | CA2604516A1 (pt) |
| CO (1) | CO6241194A2 (pt) |
| DE (1) | DE602006007976D1 (pt) |
| DK (1) | DK1877052T3 (pt) |
| ES (1) | ES2330468T3 (pt) |
| HR (1) | HRP20090453T1 (pt) |
| IL (1) | IL185371A0 (pt) |
| MX (1) | MX2007012624A (pt) |
| NO (1) | NO20075793L (pt) |
| NZ (1) | NZ560939A (pt) |
| PL (1) | PL1877052T3 (pt) |
| PT (1) | PT1877052E (pt) |
| RU (1) | RU2405779C2 (pt) |
| WO (1) | WO2006108800A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009518292A (ja) | 2005-12-05 | 2009-05-07 | ノイロサーチ アクティーゼルスカブ | ベンズイミダゾール誘導体及びgabaa受容体複合体を調節するためのそれらの使用 |
| TWI391381B (zh) | 2006-03-24 | 2013-04-01 | Neurosearch As | 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途 |
| WO2010055126A1 (en) * | 2008-11-14 | 2010-05-20 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| WO2010055124A1 (en) * | 2008-11-14 | 2010-05-20 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| WO2010055125A1 (en) * | 2008-11-14 | 2010-05-20 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| RU2452486C1 (ru) * | 2011-04-13 | 2012-06-10 | Общество с ограниченной ответственностью "Лечебно-реабилитационный научный центр "Феникс" | Способ фармакотерапии панического расстройства |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK40192D0 (da) | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| CA2218493C (en) | 1995-04-21 | 2005-02-22 | Neurosearch A/S | Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| CN1115336C (zh) * | 1996-10-21 | 2003-07-23 | 神经研究公司 | 1-苯基-苯并咪唑类化合物及其作为baga-a受体调节剂的用途 |
| NZ503435A (en) | 1997-10-10 | 2001-12-21 | Neurosearch As | Oxime substituted 1-(3-(heteroaryl)phenyl)-benzimidazole compounds having GABA activity |
| RU2243226C2 (ru) * | 1999-06-22 | 2004-12-27 | НьюроСёрч А/С | Новые производные бензимидазола и содержащие эти соединения фармацевтические композиции |
| WO2002050057A1 (en) * | 2000-12-20 | 2002-06-27 | Neurosearch A/S | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders |
| JP2006522070A (ja) * | 2003-04-03 | 2006-09-28 | ニューロサーチ、アクティーゼルスカブ | ベンズイミダゾール誘導体及びこれをgabaa受容体複合体をモジュレートするために使用する方法 |
| JP2006522069A (ja) * | 2003-04-03 | 2006-09-28 | ニューロサーチ、アクティーゼルスカブ | ベンズイミダゾール誘導体及びこれをgabaa受容体複合体をモジュレートするために使用する方法 |
| AU2004268949A1 (en) * | 2003-08-21 | 2005-03-10 | Osi Pharmaceuticals, Inc. | N-substituted benzimidazolyl C-kit inhibitors |
| US7700638B2 (en) * | 2003-10-23 | 2010-04-20 | N. V. Organon | 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| JP2008521903A (ja) * | 2004-12-01 | 2008-06-26 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー |
| TWI391381B (zh) | 2006-03-24 | 2013-04-01 | Neurosearch As | 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途 |
-
2006
- 2006-04-07 NZ NZ560939A patent/NZ560939A/en not_active IP Right Cessation
- 2006-04-07 WO PCT/EP2006/061417 patent/WO2006108800A1/en not_active Ceased
- 2006-04-07 ES ES06725630T patent/ES2330468T3/es active Active
- 2006-04-07 PL PL06725630T patent/PL1877052T3/pl unknown
- 2006-04-07 DK DK06725630T patent/DK1877052T3/da active
- 2006-04-07 AU AU2006233894A patent/AU2006233894A1/en not_active Abandoned
- 2006-04-07 CA CA002604516A patent/CA2604516A1/en not_active Abandoned
- 2006-04-07 MX MX2007012624A patent/MX2007012624A/es active IP Right Grant
- 2006-04-07 US US11/887,780 patent/US7851490B2/en not_active Expired - Fee Related
- 2006-04-07 DE DE602006007976T patent/DE602006007976D1/de active Active
- 2006-04-07 JP JP2008505868A patent/JP2008535891A/ja not_active Abandoned
- 2006-04-07 RU RU2007137096/04A patent/RU2405779C2/ru not_active IP Right Cessation
- 2006-04-07 EP EP06725630A patent/EP1877052B1/en active Active
- 2006-04-07 KR KR1020077023521A patent/KR20070119691A/ko not_active Withdrawn
- 2006-04-07 HR HR20090453T patent/HRP20090453T1/hr unknown
- 2006-04-07 PT PT06725630T patent/PT1877052E/pt unknown
-
2007
- 2007-08-20 IL IL185371A patent/IL185371A0/en unknown
- 2007-10-09 CO CO07105966A patent/CO6241194A2/es not_active Application Discontinuation
- 2007-11-12 NO NO20075793A patent/NO20075793L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ560939A (en) | 2010-07-30 |
| EP1877052B1 (en) | 2009-07-22 |
| NO20075793L (no) | 2008-01-14 |
| ES2330468T3 (es) | 2009-12-10 |
| RU2007137096A (ru) | 2009-05-20 |
| IL185371A0 (en) | 2008-02-09 |
| DK1877052T3 (da) | 2009-10-12 |
| WO2006108800A1 (en) | 2006-10-19 |
| EP1877052A1 (en) | 2008-01-16 |
| PL1877052T3 (pl) | 2010-01-29 |
| MX2007012624A (es) | 2008-01-11 |
| DE602006007976D1 (de) | 2009-09-03 |
| JP2008535891A (ja) | 2008-09-04 |
| CO6241194A2 (es) | 2011-01-20 |
| US7851490B2 (en) | 2010-12-14 |
| AU2006233894A1 (en) | 2006-10-19 |
| US20090036493A1 (en) | 2009-02-05 |
| KR20070119691A (ko) | 2007-12-20 |
| RU2405779C2 (ru) | 2010-12-10 |
| CA2604516A1 (en) | 2006-10-19 |
| HRP20090453T1 (hr) | 2009-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL192297A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| NL301192I2 (nl) | Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan | |
| HUS2000031I1 (hu) | Benzimidazol-származékok | |
| IL188039A0 (en) | Oxindole derivatives | |
| ZA200710192B (en) | Substituted arylpyrazoles for use against parasitites | |
| EP2124024A4 (en) | WEIGHT STUDY AND WEIGHT STUDY SYSTEM THEREWITH | |
| IL195821A0 (en) | Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors | |
| ZA200805679B (en) | Cyclohexyl piperazinyl methanone derivatives and their use as histamine H3 receptor modulators | |
| IL193475A0 (en) | Benzimidazole derivatives | |
| EP2153805A4 (en) | DEVICE FOR PENIS EXTENSION | |
| IL185371A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| IL176630A0 (en) | Benzimidazole derivatives | |
| SI1863801T1 (sl) | Benzimidazolni derivat in njegova uporaba | |
| PL1938116T3 (pl) | Urządzenie do pomiaru współczynnika strat | |
| ZA200803561B (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| ZA200707426B (en) | Benzimidazole derivatives and their use for modulating the GABAA receptor complex | |
| ZA200805904B (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| ATE489386T1 (de) | Naphthyridin-derivate | |
| DE112007000029A5 (de) | Sende-/Empfangsvorrichtung zum simultanen Senden und Empfangen und Verwendung der Sende-/Empfangsvorrichtung | |
| GB0516946D0 (en) | Receptor | |
| TWI348529B (en) | Light source connecting device and the replaceable light source structure for using the same | |
| ZA200908626B (en) | Benzimidazole Derivatives | |
| GB0503111D0 (en) | Receptor agonists and their use | |
| GB0709217D0 (en) | Bicyclc and heterobicyclic derivatives, proccesses for preparing them and their uses | |
| FI7413U1 (fi) | Pelastuslaite |